Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28639221 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29402455 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL2385522 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL1974553 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL442439 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL16286530 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL4642459 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL2388478 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL28894227 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 | |
| SCHEMBL29737750 | 0.98 | TSHR (0.66) | TSHRALDH1A1CYP3A4HPGDTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3730121-B1 | DENTAL ADHESIVE MATERIAL KIT | KURARAY NORITAKE DENTAL INC (JP) | 2023-10-25 | — | — | EP | claimed |
| US-11484477-B2 | Dental adhesive material kit | KURARAY NORITAKE DENTAL INC. (JP) | 2022-11-01 | — | — | US | claimed |
| CN-107664919-B | Method for producing patterned cured product and patterned cured product obtained thereby | 三星显示有限公司 | 2022-10-14 | — | — | CN | claimed |
| EP-3310792-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-07-21 | — | — | EP | claimed |
| US-10744684-B2 | Method of preparing patterned cured product and patterned cured product obtained using the method | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-08-18 | — | — | US | claimed |
| US-20180029255-A1 | METHOD OF PREPARING PATTERNED CURED PRODUCT AND PATTERNED CURED PRODUCT OBTAINED USING THE METHOD | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-01 | — | — | US | claimed |
| EP-2398768-A1 | PYRROLIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2011-12-28 | — | — | EP | claimed |
| WO-2010094667-A1 | PYRROLIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-08-26 | — | — | WO | claimed |
| US-20050048200-A1 | PROCESS FOR PREPARING AN OPTICAL WAVEGUIDE COMPONENT FROM ACRYLATE/TITANIUM ALKOXIDE COMPOSITE MATERIAL AND THE PREPARED OPTICAL WAVEGUIDE COMPONENT | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-03-03 | — | — | US | claimed |
| US-6852358-B1 | Process for preparing an optical waveguide component from acrylate/titanium alkoxide composite material and the prepared optical waveguide component | CHANG CHUN PLASTICS CO., LTD. (TW) | 2005-02-08 | — | — | US | claimed |
| EP-4747320-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-05-21 | — | — | US | disclosed |
| CN-122054878-A | Method for manufacturing light-emitting device, negative-type radiation-sensitive composition, cured film, and organic EL device | JSR株式会社 | 2026-05-15 | — | — | CN | disclosed |
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4717249-A1 | DENTAL COMPOSITION | Shofu Inc. (JP) | 2026-04-01 | — | — | EP | disclosed |
| EP-0430722-A2 | Curable insulating material | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-06-05 | — | — | EP | disclosed |
| US-4884866-A | OPTICAL FIBERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1989-12-05 | — | — | US | disclosed |
| US-4786658-A | ACRYLIC ESTER POLYMER, CLADDING FOR OPTICAL FIBERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1988-11-22 | — | — | US | disclosed |
| US-4749727-A | THREE-DIMENSIONAL CROSSLINKING; EPOXIDES, UNSATURATED ALKOXYSILANES; WATER CURABLE | KANSAI PAINT CO., LTD. (JP) | 1988-06-07 | — | — | US | disclosed |
| EP-0243605-A2 | Fluorine-containing resin composition having a low refractive index | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1987-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | MAT1A, MAT2B, MAT2A | TSHR 2841/4885ALDH1A1 139/4885CYP3A4 3827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.